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Abstract
Purpose The currently recommended double reading of all screening mammography examinations is an economic burden 
for screening programs. The sensitivity of screening is higher for women with low breast density than for women with high 
density. One may therefore ask whether single reading could replace double reading at least for women with low density. 
We addressed this question using data from a screening program where the radiologists coded their readings independently.
Methods Data include all screening mammography examinations in the Capital Region of Denmark from 1 November 
2012 to 31 December 2013. Outcome of screening was assessed by linkage to the Danish Pathology Register. We calculated 
sensitivity, specificity, number of interval cancers, and false positive-tests per 1000 screened women by both single reader 
and consensus BI-RADS density code.
Results In total 54,808 women were included. The overall sensitivity of double reading was 72%, specificity was 97.6%, 3 
women per 1000 screened experienced an interval cancer, and 24 a false-positive test. Across all BI-RADS density codes, 
single reading consistently decreased sensitivity as compared with consensus reading. The same was true for specificity, 
apart from results across BI-RADS density codes set by reader 2.
Conclusions Single reading decreased sensitivity as compared with double reading across all BI-RADS density codes. This 
included results based on consensus BI-RADS density codes. This means that replacement of double with single reading 
would have negative consequences for the screened women, even if density could be assessed automatically calibrated to 
the usual consensus level.
Keywords Mammography · Screening · Single reading · Double reading · Sensitivity · Specificity
Background
The European Guidelines for quality assurance in breast can-
cer screening and diagnosis [1] recommend that a mammo-
gram is read independently by two radiologists; also called 
double reading. According to the Guidelines, double reading 
enhances the sensitivity of the screening test with 5–15%, 
and sensitivity is certainly important to a screening program 
as it measures the ability of the screening test to find the 
cancers. Both the risk of breast cancer and the sensitivity 
of the screening test furthermore depend on the density of 
the breast tissue [2]. Breast density is often reported in four 
categories according to a system developed by American 
College of Radiology called Breast Imaging-Reporting and 
Data System (BI-RADS) [3].
In the population-based screening program of the Capital 
Region of Denmark, data have been collected on the out-
come of the mammogram reading for each radiologist sepa-
rately. This included both the BI-RADS density code and the 
categorization of the screening mammogram as negative or 
positive of malignancy. Women with negative mammogra-
phy examinations were returned to routine screening, and 
women with positive mammography examinations were fol-
lowed up with triple diagnostics.
European Guidelines require that a least one of the radiol-
ogist performing double reading of screening mammography 
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examinations reads at least 5000 mammography examina-
tions per year [1]. The limited number of qualified screen-
ing radiologists is a challenge, and double reading is a 
financial burden for the screening programs. On this basis, 
one may ask whether double reading of all mammography 
examinations is needed. Therefore, we took advantage of 
the BI-RADS density coded data from the Capital Region 
of Denmark to investigate the impact on the sensitivity and 
specificity of double versus single reading of mammography 
examinations stratified by level of breast density.
Methods
Screening
The Capital Region of Denmark offers biennial screening 
to women aged 50–69 years. Women are personally invited 
to visit one of the 5 mammography screening clinics in the 
region. The program uses the Siemens Inspiration digital 
mammography equipment. At screening, the radiographer 
takes a craniocaudal and an oblique view.
All mammography examinations are read and coded 
independently by two trained radiologists. If the two readers 
agree, the consensus code is their common code. If the two 
readers disagree on the malignancy code, a consensus code 
is made in dialog between the two readers, and if necessary 
a third independent reader is brought in. If the two readers 
disagree on the BI-RADS density code, the highest code is 
used as the consensus code. Normally, junior readers are first 
readers, but a given reader can advance to become second 
reader after some experience. So within the program, a given 
reader can therefore have acted in both roles.
In our dataset, breast density has been coded accord-
ing to the 2003, 4th Edition of the BI-RADS density code 
[3]. BI-RADS 1 is fatty; where the breast is almost entirely 
fat (< 25% fibroglandular tissue); BI-RADS 2 is scattered 
(> 25–50%) fibroglandular; BI-RADS 3 is heterogeneously 
(51%-75%) dense; and BI-RADS 4 is dense (> 75%).
Study base
We retrieved data on all screening mammography examina-
tions from 1 November 2012 to 31 December 2013. Within 
the study period, no woman was screened more than once. 
The mammography register holds information on screening 
date, the outcome of each independent reading (including 
negative/positive code and BI-RADS density code), and the 
consensus outcome.
The outcome of screening was assessed by linkage to 
the Danish Pathology Register based on unique personal 
identification numbers used in both the screening regis-
ter and in the pathology register. Women with a positive 
screening test and breast cancer or ductal carcinoma 
in situ (DCIS) diagnosed within 6 months of the screen-
ing date were defined as screen-detected cancers. Other 
women were followed up until next screening date or for 
24 months whichever came first; for simplicity called 24 
months. Women with a negative screening test and breast 
cancer/DCIS diagnosed within 24 months after the screen-
ing date or with a positive screening test and diagnosed 
with breast cancer/DCIS within 7–24 months after the 
screening date were defined as interval cancers. Women 
with screen-detected cancers and women with interval 
cancers together constituted the truly sick women. Women 
with a positive screening test and no diagnosis of breast 
cancer/DCIS were defined as false positive; and women 
with a negative screening test and no breast cancer/DCIS 
were defined as truly negative. The two latter groups 
together constituted the truly healthy women.
Analysis
First, we calculated sensitivity (= screen detected/truly sick) 
and specificity (= truly negative/truly healthy) for Reader 1 
both overall and by BI-RADS density code as set by Reader 
1. We compared with the outcome of the consensus read-
ing for the same group of women. In this calculation, the 
extra screen-detected cases in the consensus reading were 
considered overlooked by Reader 1 and therefore added as 
interval cancers for Reader 1, and the extra interval cancers 
in the consensus reading in women originally deemed posi-
tive by Reader 1 but reclassified as negative in the consensus 
reading were added as screen-detected cancers for Reader 1, 
Table 1. We calculated also the number of women with inter-
val cancers and the number of women with a false-positive 
screening test per 1000 screened women.
Second, we calculated the same measures for Reader 2 
both overall and by BI-RADS density code as set by Reader 
2. Third, we calculated the four measures for Reader 1, 
Reader 2, and for the consensus reading now using the con-
sensus BI-RADS density code. The purpose of the first and 
second analyses was to measure the consequences of using 
one reader only as compared with the current consensus 
reading. The purpose of the third analysis was to measure the 
consequences of using one reader only in the hypothetical 
situation where the BI-RADS density code could be assessed 
automatically calibrated to the usual consensus level. 95% 
confidence interval for sensitivity and specificity are “exact” 
Clopper-Pearson confidence intervals [4]. Working under the 
assumption of independence between the readers, p values 
for difference in sensitivity and specificity were calculated 
using McNemar’s exact test. Statistical analyses were car-
ried out with SAS 9.4. All plots were done in R 3.2.1, with 
ggplot2 and gridExtra packages.
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Results
There were 54,808 women in the study population. The 
majority of the mammography examinations, 69%, were 
read by radiologists who for different mammography exami-
nations had acted both as first and second reader, and 31% of 
the mammography examinations were read by radiologists 
who had acted only as either first or second reader in the 
program. Reader 1 coded the mammography examinations 
from 3.5% of the women as positive; while this was the case 
for 3.0% of the women for Reader 2; and 3.1% in the consen-
sus coding. Reader 1 found cancers in 0.68% of the women; 
while Reader 2 found cancers in 0.63% of the women. Con-
sensus coding increased this percentage to 0.78%. Reader 1 
had more women with false-positive outcome, 2.85%, than 
Reader 2, 2.36%, and the consensus code resulted in 2.35%.
Reader 1 coded 34% of the mammography examinations 
with BI-RADS density code 1, Table 2, and this propor-
tion was the same for Reader 2, 35%, Table 3. There was, 
however, a considerable inconsistency in the density cod-
ing between the two readers, as both readers agreed on BI-
RADS density code 1 for only 28% of the mammography 
examinations, Table 4. The proportion of mammography 
examinations with BI-RADS density code 2 ended up being 
almost the same for the three reader outcomes; 39%; 39%, 
and 40%, respectively. The proportions of mammography 
examinations with BI-RADS density codes 3 and 4 were 
as expected higher for the consensus outcome than for each 
of the individual readers. For BI-RADS density code 3 the 
proportions were 23%; 22%; and 27%, respectively. For BI-
RADS density code 4, 4%; 3%; 5.0%, respectively, Tables 1, 
2, and 3.
The overall sensitivity for the consensus outcome was 
72.0% and the specificity was 97.6%. Per 1000 screened 
women, 3.0 women experienced an interval cancer and 23.5 
women had a false-positive screening test, Table 4. Reader 
1 had an overall lower sensitivity of 65.6% (p < 0.0001) and 
a somewhat lower specificity of 97.1% (p < 0.0001). Reader 
2 had an overall sensitivity of 61.6%(p < 0.0001), and the 
same specificity of 97.6% (p = 0.9498) as in the consensus 
reading, Tables 2 and 3.
When the mammography examinations were divided 
into the BI-RADS density groups set by Reader 1, both 
the sensitivity and the specificity for Reader 1 was lower 
than in the current consensus reading, e.g., for the 18,666 
mammography examinations that Reader 1 coded as 
BI-RADS density code 1, Reader 1 had a sensitivity of 
71.3% as compared with 76.9% in the consensus coding 
(p = 0.0215), Table 2 and Fig. 1. When the mammography 
examinations are divided into the BI-RADS density groups 
Table 1  Number of screen 
detected and interval cancer in 
the Capital Region of Denmark 
2012–2013 by reader (Reader 1, 
Reader 2, and Consensus) and 
by BI-RADS density code (as 
assesses by Reader 1, Reader 2, 
and in the Consensus reading)
SDC Screen detected cancer, IC Interval cancer
Truly sick in 
Consensus read-
ing
Truly sick in Reader 1 reading Truly sick in Reader 2 reading
By Reader 1 BI-
RADS code
By Consensus BI-
RADS code
By Reader 2 BI-
RADS code
By Consensus BI-
RADS code
SDC IC Total SDC IC Total SDC IC Total SDC IC Total
All BI-RADS
 SDC 370 46 416 370 46 416 347 69 416 347 69 416
 IC 9 153 162 9 153 162 9 153 162 9 153 162
 Total 379 199 578 379 199 578 356 222 578 356 222 578
BI-RADS 1
 SDC 101 9 110 81 7 88 92 19 111 70 18 88
 IC 1 32 33 1 24 25 1 31 32 1 24 25
 Total 102 41 143 82 31 113 93 50 143 71 42 113
BI-RADS 2
 SDC 170 22 192 162 22 184 164 28 192 159 25 184
 IC 6 55 61 5 56 61 5 63 68 4 57 61
 Total 176 77 253 167 78 245 169 91 260 163 82 245
BI-RADS 3
 SDC 90 13 103 112 15 127 85 18 103 105 22 127
 IC 1 53 54 2 55 57 2 45 47 3 54 57
 Total 91 66 157 114 70 184 87 63 150 108 76 184
BI-RADS 4
 SDC 9 2 11 15 2 17 6 4 10 13 4 17
 IC 1 13 14 1 18 19 1 14 15 1 18 19
 Total 10 15 25 16 20 36 7 18 25 14 22 36
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set by Reader 2, the sensitivity for Reader 2 was lower 
than in the current consensus reading, and the specificity 
remained at the same level, e.g., for the 19,307 mammog-
raphy examinations that Reader 2 coded as BI-RADS den-
sity code 1, Reader 2 had a sensitivity of 65.0% as com-
pared with 77.6% in the consensus coding (p < 0.0001), 
Table 3 and Fig. 2.
When the mammography examinations were divided 
into the BI-RADS density groups set at the consensus 
reading both Reader 1 and Reader 2 had lower sensi-
tivity for all BI-RADS density groups than found at the 
consensus reading. It should be noted though that for the 
15,587 women with consensus BI-RADS density code 1; 
where Reader 1 had a sensitivity of 72.6%; Reader 2 of 
62.8%, and the consensus reading of 77.9%, Table 4 and 
Fig. 3, there was no statistically significant difference in 
sensitivity between Reader 1 and the consensus reading 
(p = 0.0703), neither difference in specificity (p = 0.3824). 
For Reader 2 the sensitivity was statistically significantly 
lower than for consensus reading (p < 0.0001). For the 
small group of 2761 women with BI-RADS density code 
4, both Reader 1 and Reader 2 had a sensitivity in line with 
that of the consensus reading (p = 1.000 and p = 0.3750, 
respectively).
Discussion
Main findings
The present days’ practice in screening mammography 
with consensus after double reading resulted in a sensi-
tivity of 72.0% and a specificity of 97.6%. The highest 
sensitivity of 77.9% was amongst women in the BI-RADS 
density code 1 and the lowest of 47.2% amongst women 
in the BI-RADS 4 density code. The specificity was fairly 
consistent, between 98.7% and 97.2%. Per 1000 screened 
women this translated into 3 women with interval cancers 
and 24 women with a false-positive screening test. Our 
study showed a loss in sensitivity, although not always 
statistically significant, across all BI-RADS density groups 
if double reading was replaced by single reading. This was 
true both in the situations where we used the BI-RADS 
density codes set by one of the two readers, and in the 
situation where we used the BI-RADS density codes set 
in the consensus reading. For BI-RADS density code 1, 
the difference in sensitivity was not statistically significant 
between Reader 1 and consensus reading when the density 
code was set in the consensus reading, and both single 
Fig. 1  Sensitivity and specificity of screening mammography for Reader 1 and Consensus, by Reader 1 BI-RADS density code
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readers had a specificity in agreement with the consensus 
reading. For BI-RADS density codes 2–3 there was a loss 
in specificity if Reader 1 was the single reader, but this 
was not the case if Reader 2 was the single reader.
Other studies
In a number of case-control studies, Boyd et al. [5] found 
odds ratios of about 4 for the risk of breast cancer when 
women with more than 75% density were compared with 
women with less than 10% density. Our data, which included 
the screen-detected and the interval cancer cases, showed 
a doubling of the odds from BI-RADS density code 1 to 
BI-RADS density code 4; from 7 to 14 cases per 1000 
screened women. In this perspective it seems reasonable 
to concentrate scarce screening resources on the high risk 
women. However, independent double reading of mammog-
raphy examinations is recommended as standard practice in 
screening programs [1]. This is justified by the overall higher 
sensitivity of double as compared to single reading [2]. Fur-
thermore, the ability of screening mammography to detect 
breast cancer decreases with increasing breast density. This 
has been shown both for radiologist assessed density [6], 
and more recently for automatically measured volumetric 
mammographic density [7].
The 34–35% of women with BI-RADS density code 1 
found in the Danish program is high in an international 
perspective. In almost 4 million screening mammography 
examinations interpreted by radiologists who participate in 
the US Breast Cancer Surveillance Consortium (BCSC), 
only about 12% had BI-RADS density code 1, it should 
though be taken into account that screening in the US started 
normally at the age of 40 years [8]. A study from New York 
of women about the age of 50 years reported a proportion 
of 10% with BI-RADS density code 1 [9]. Similarly, in the 
German data reported by Weigel et al. [10], only 6% had 
BI-RADS density code 1. In data from the Norwegian breast 
cancer screening program, the distribution from BI-RADS 1 
to 4 was 16%, 56%, 24%, and 4% [11]. In data from Malmö, 
Sweden, the distribution was 16%, 41%, 35%, and 8% [12].
Weigel et al. [10] reported data from 25,579 women 
screened age 50–69  years. The data came from a sin-
gle screening unit in Germany, where abnormal findings 
detected by one or both readers resulted in mandatory con-
sensus meeting of the two readers with a third.
Using the highest case reading, the overall sensitivity 
was 80.0%; 83.1% for mammography examinations with BI-
RADS density code 2; 80.7% for BI-RADS density code 3; 
and 100% and 50%, respectively, for the small proportions of 
mammography examinations with either BI-RADS density 
Fig. 2  Sensitivity and specificity of screening mammography for Reader 2 and Consensus, by Reader 2 BI-RADS density code
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code 1 or 4. It was not possible from the published data for 
calculate sensitivity by BI-RADS density code for single 
readers. To our knowledge no study previous to our’s has 
addressed the comprehensive impact of the reading schedule 
and breast density.
Reader 1 is normally the junior reader. It could therefore 
seem surprising that Reader 1 had a systematic, although 
statistically borderline non-significant, higher sensitivity 
than Reader 2, (p = 0.0505) This is, however, in agreement 
with the results of studies comparing radiographer and radi-
ologist reading. In the UK National Health Service Breast 
Screening Program, screening units with radiographers had 
the same cancer detection rate as screening units with radi-
ologists [13]. The recall rate was, however, higher in the 
units with radiographers than in the units with radiologists. 
In our data, Reader 1 has a statistically significant lower 
specificity than Reader 2, (p < 0.0001). This could indicate 
that the most difficult task in reading of mammograms is to 
avoid overcall.
Strength and weaknesses
Our data derived from a population-based screening pro-
gram. During the study period, the coverage of exami-
nation of targeted women was 73% [14]. Follow-up was 
complete because all diagnoses of breast cancer and DCIS 
are recorded in the Danish Pathology Register, and linkage 
to this register is possible based on the unique personal 
identification numbers. However, despite having a large 
data set, only 3–4% of the mammography examinations 
were coded with BI-RADS density code 4 by the individ-
ual readers. This meant that we had relatively few breast 
cancer cases in this high density group. The conclusions 
should be seen with reservations for wide and overlapping 
confidence intervals.
Conclusion
Our study showed a loss in sensitivity - and to a lesser 
extent in specificity – meaning that the current double 
reading cannot be replaced by single reading without nega-
tive consequences for the screened women. This is true 
even if the BI-RADS density code could be set automati-
cally calibrated to the usual consensus level. In the latter 
case, single reading could in some situation depending on 
the reader eventually be considered for women with BI-
RADS density code 1.
Fig. 3  Sensitivity and specificity of screening mammography for Reader 1, Reader 2 and Consensus, by Consensus BI-RADS density code
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